Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) Short Interest Up 106.5% in March

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) was the recipient of a significant increase in short interest in March. As of March 31st, there was short interest totalling 15,900 shares, an increase of 106.5% from the March 15th total of 7,700 shares. Based on an average daily volume of 56,600 shares, the short-interest ratio is presently 0.3 days.

Reviva Pharmaceuticals Stock Up 22.4 %

RVPHW stock opened at $0.05 on Thursday. The firm has a 50-day moving average of $0.09 and a two-hundred day moving average of $0.15. Reviva Pharmaceuticals has a one year low of $0.02 and a one year high of $0.78.

Reviva Pharmaceuticals Company Profile

Reviva Pharmaceuticals Holdings, Inc, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is brilaroxazine (RP5063), which is in Phase III clinical trials for use in the treatment of schizophrenia, as well as completed Phase I clinical trials to treat bipolar disorder, major depressive disorder, attentiondeficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis.